HKHyunhee Kim

Hyunhee Kim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hyunhee Kim has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comprehensive Classification of Surgically Resected Pituitary Neuroendocrine Tumors: Updates From a Single-Institution Experience Based on the WHO 5th Edition

    by Hyunhee Kim, Eric Eunshik Kim, Yong Hwy Kim, Jin Woo Park, Kyeong Cheon Jung, Haeryoung Kim, Jae Kyung Won, Sung-Hye Park

    Kim H, et al. J Korean Med Sci. 2024 Dec;40(16):e56. https://doi.org/10.3346/jkms.2025.40.e56


  • Neuroepithelial tumor with EWSR1::PATZ1 fusion: A literature review

    by Hyunhee Kim, Kwanghoon Lee, Ji Hoon Phi, Sun Ha Paek, Hongseok Yun, Seung Hong Choi, Sung-Hye Park

    We present the clinicopathological and molecular genetic characteristics of a neuroepithelial tumor (NET), EWSR1::PATZ1 fusion-positive with a literature review. This fusion has recently been discovered in rare central nervous system tumors and soft tissue sarcomas and was not included in the fifth edition of the WHO classifications. We identified this fusion in 2 NETs. The first case involved a 7-year-old girl and the second case occurred in a 53-year-old man; both presented with headaches and vomiting. The pediatric case initially showed an intermediate grade of the tumor, but upon recurrences, it transformed into a high-grade tumor with 2 relapses in 8.3 years. This case exhibited high mitotic activity (20/10 high-power fields), and a high Ki-67 index (21%). The TERT promoter (TERTp) mutation was present in both initial and recurrent tumors. In contrast, the adult case was a low-grade tumor with no mitotic activity or recurrence over 13.5 months after subtotal resection and gamma knife surgery. Interestingly, the pediatric case demonstrated a longer survival time compared to conventional glioblastoma. The TERTp mutation, similar to being a molecular signature in adult-type glioblastoma, could also be an indicator of high-grade behavior in PATZ1 fusion NET.


  • Working Class Stratification and the Demand for Unionization1

    by Hyunhee Kim

    Theories of working class stratification, such as homogenization and segmentation theses, have tended to deterministically derive and impute the demand for unionization to structural conditions and/or status divisions among workers. In the theoretical framework of the homogenization thesis, the roles of human agents, such as workers, union leaders, and employers, are not incorporated and individual differentiation in the demand for unionization is neglected. The segmentation thesis only emphasizes the negative effect of stratification within the working class on the demand for unionization. It does not elaborate the conditions under which the demand for unionization is promoted or hindered.

  • The Impact of Socioeconomic Status on Worker Dispositions to Unionize

    by Hyunhee Kim

    With respect to the relationship between worker socioeconomic status and dispositions to unionize, little systematic and theoretical research has been done. Although the industrial relations researchers have been interested in desire to unionize, their research process has been inductive and provided post-hoc explanations rather than theoretical. These researchers tend to include individual characteristics, which are typical ones to be included in a questionnaire, in the analysis of worker dispositions to unionize. These researchers also have not systematically related individual characteristics with structural or attitudinal variables.

  • Social Inequality and Unionization

    by Hyunhee Kim

    The U.S. labor movement has suffered from membership decline during the post-World War era. Between 1945 and 1994, the percentage of unionized workers in the nonagricultural labor force has steadily declined from 35.5% to 15.5% (U.S. Bureau of Labor Statistics, 1995). The size of the labor movement is critical to an understanding of the role in society of collective bargaining. Ebbs and flows in the size of the labor movement give us a sense of the health of the labor movement in its role as a countervailing force and protector of workers’ interests vis-a-vis employers. The issue of union growth had never been more critical than in the 1990s, since the extent of union decline has gathered a seemingly unstopable momentum which threatens the very core of private sector collective bargaining (Seeber, 1991).

  • Race Differences in the Determinants of Worker Dispositions to Unionize

    by Hyunhee Kim

    Although the traditional patterns of race discrimination against blacks 1 has been improved in the labor market practices due to the Civil Rights movement and Affirmative Action, race is still one of the important determinants of social stratification, partly because the improvements and remedies are only applied for some segments of black population (Lieberson, 1980; Wilson, 1980, 1987). In other words, the recent collapse of traditional discriminatory patterns has increased job opportunities for the more-talented and highly-educated segments of black population; in contrast, the relatively poorly trained blacks of inner city find themselves locked in the low-wage sector (e.g., operative, laborer, and service-worker jobs).

  • Age Differences in the Determinants of Worker Dispositions to Unionize

    by Hyunhee Kim

    Although the union membership rate of older workers 1 is higher than that of younger workers, this does not necessarily mean that older workers have stronger dispositions to unionize than younger workers. 2 The existing studies on voting intentions to unionize, including the result of Chapter II, indicate that younger workers are more prone to unionize than older workers, with some exceptions. In addition, some of these studies show that there are no age differences in dispositions to unionize by including an age variable and attitudinal intervening variables, which may explain away an age effect, in the same equation.

  • Coexistence of dentatorubral‐pallidoluysian atrophy and Parkinson's disease: An autopsy case report

    by Seong‐Ik Kim, Hyunhee Kim, Jin Woo Park, Ji‐Hyun Choi, Han Joon Kim, Jae Kyung Won, Beomseok Jeon, Sung‐Hye Park

    We report an autopsy case of a 56‐year‐old male patient with the coexistence of dentatorubral‐pallidoluysian atrophy (DRPLA) and Parkinson's disease (PD). He presented with gait instability and dysarthria for 10 years. The removed brain showed general atrophy (988 g) with depigmentation of the substantia nigra. The neocortex and deep gray matter, including the red nucleus, subthalamic nuclei, and globus pallidus, were atrophic, and grumose degeneration of the cerebellar dentate nucleus was observed. Polyglutamine‐ and p62‐positive neuronal inclusions were present and widespread in the areas mentioned above. Interestingly, this case also had brainstem‐predominant PD pathology with α‐synuclein‐positive Lewy bodies and Lewy neurites. Generalized white matter atrophy with patchy loss of astrocytes in the white matter suggested glial dysfunction by elongated CAG repeats in the atrophin 1 gene (atrophin 1). Polymerase chain reaction (PCR) fragment analysis revealed increased CAG repeats (61) on atrophin 1 encoding atrophin 1. The patient had a family history of DRPLA, including his daughter, who was confirmed positive on genetic testing (CAG repeat: 65). His father, brother, and niece were suspected of having the disease. Clinicopathologically, all of the above findings are consistent with the coexistence of DRPLA and PD. So far, various overlapping neurodegenerative disorders have been reported, but the coexistence of DRPLA and PD has never been demonstrated in the published literature. Even though the exact time of PD development is unknown in this case, PD might develop after DRPLA, and the overwhelming symptoms of DRPLA might mask those of PD. Here, we report a clinicopathologically definite case of the coexistence of DRPLA and PD. White matter degeneration with patchy loss of astrocytes was another remarkable finding of this case.


  • Open Access

    The prognostic significance of p16 expression pattern in diffuse gliomas

    by Jin Woo Park, Jeongwan Kang, Ka Young Lim, Hyunhee Kim, Seong-Ik Kim, Jae Kyung Won, Chul-Kee Park, Sung-Hye Park

    CDKN2A is a tumor suppressor gene that encodes the cell cycle inhibitor protein p16. Homozygous deletion of the CDKN2A gene has been associated with shortened survival in isocitrate dehydrogenase (IDH)-mutant gliomas. This study aimed to analyze the prognostic value of p16 and to evaluate whether p16 immunohistochemical staining could be used as a prognostic marker to replace CDKN2A genotyping in diffuse gliomas. p16 immunohistochemistry was performed on tissue microarrays of 326 diffuse gliomas with diagnoses that reflected IDH-mutations and 1p/19q codeletion status. The results were divided into three groups (negative, focal expression, overexpression) according to the presence and degree of p16 expression. Survival analysis was performed to assess the prognostic value of p16 expression. A loss of p16 expression predicted a significantly worse outcome in all glioma patients (n=326, p<.001), in the IDH-mutant glioma patients (n=103, p=.010), and in the IDH-mutant astrocytoma patients (n=73, p=.032). However, loss of p16 expression did not predict the outcome in the IDH-wildtype glioma patients (n=223, p=.121) or in the oligodendroglial tumor patients with the IDH-mutation and 1p/19q codeletion (n=30, p=.457). Multivariate analysis showed the association was still significant in the IDH-mutant glioma patients (p=.008; hazard ratio [HR], 2.637; 95% confidence interval [CI], 1.295 to 5.372) and in the IDH-mutant astrocytoma patients (p=.001; HR, 3.586; 95% CI, 1.649 to 7.801). Interestingly, patients who presented with tumors with p16 overexpression also had shorter survival times than did patients with tumors with p16 focal expression in the whole glioma (p< .001) and in IDH-mutant glioma groups. (p=.046). This study suggests that detection of p16 expression by immunohistochemistry can be used as a useful surrogate test to predict prognosis, especially in IDH-mutant astrocytoma patients.